Re: Am I dumb?
The new CEO, who bought much open market, has a stellar record with forming partnerships.
I thought he should have signed one sooner, but I believe interested partners are waiting for the FDA meeting, which will inform much about what will be required.
I do believe the insti are positive about it, but await clarity.
ARDS isn't dead, and it's easier in Japan to get stem cell drugs approved.
Its partner in Japan, Healios, is doing the work there.
If they have to sell more stock instead, that will be brutal.
As stated, I'm bullish but have not bought shares recently. I felt like buying a nice dip which never came. It's so far above 50d and overbought.
When ADX is rising, showing a strenthening trend, I do not fade the trend until it gets to an extreme level like now with ADX at 50.
But I plan to hold.
If something great happens and it gaps up I may chase it if I can get in at a decent price.
News changes fundamentals, technicals, and sentiment - looks to me like retail is very bullish.
Every biotech has a unique situation, no two are alike.
I'm a trader, tiny bit investor, and I know very little about pharma and biology - only what is obvious with a layman understanding.
|return to message board, top of board|